Landstar to Release First Quarter Results on Wednesday, April 22, 2020
JACKSONVILLE, Fla., April 08, 2020 (GLOBE NEWSWIRE) — Landstar System, Inc. (NASDAQ:LSTR), a worldwide, asset-light provider of integrated transportation management […]
TELIGENT, INC. ANNOUNCES FOURTH QUARTER AND YEAR END 2019 RESULTS & AMENDMENTS TO EXISTING SECURED CREDIT FACILITIES
BUENA, N.J., April 08, 2020 (GLOBE NEWSWIRE) — Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today […]
Pacific Biosciences Powers SARS-CoV-2 Research at Commercial, Academic and Government Labs
LabCorp, UC San Diego and the National Institute of Allergy and Infectious Diseases are among the organizations utilizing PacBio’s highly […]
VitalHub Announces Deployment of COVID-19 Electronic Screening Tool for Long Term Care
TORONTO, April 08, 2020 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) announced today the first deployment […]
Steve Hamil to Join Ebix as Global Chief Financial Officer
JOHNS CREEK, Ga., April 08, 2020 (GLOBE NEWSWIRE) — Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of On-Demand software […]
Athabasca Minerals Announces AMI RockChain Completion of $1 Million Order and Corporate Update
CALGARY, Alberta, April 08, 2020 (GLOBE NEWSWIRE) — Athabasca Minerals Inc. (“AMI” or the “Corporation”) – TSXV:AMI – is pleased […]
Myriad Withdrawing Financial Guidance for FY2020 Due to Business Impact from Coronavirus Pandemic
SALT LAKE CITY, April 08, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, […]
NextCure to Present at the 19th Annual Needham Virtual Healthcare Conference
BELTSVILLE, Md., April 08, 2020 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and […]
Clearside Biomedical to Present at the Needham Virtual Healthcare Conference
ALPHARETTA, Ga., April 08, 2020 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments […]
Chiasma Enters Into Revenue Interest Financing Agreement for up to $75 Million with Healthcare Royalty Partners
NEEDHAM, Mass., April 08, 2020 (GLOBE NEWSWIRE) — Chiasma, Inc. (NASDAQ: CHMA), a clinical, late-stage biopharmaceutical company focused on improving […]
